The G1556S-type tuberin variant suppresses tumor formation in tuberous sclerosis 2 mutant (Eker) rats despite its deficiency in mTOR inhibition.
Shiono M, Kobayashi T, Takahashi R, Sun G, Abe M, Zhang D, Wang L, Piao X, Takagi Y, Mineki R, Taka H, Tada N, Sonobe S, Momose S, Ueda M, Hino O.
Shiono M, et al. Among authors: kobayashi t.
Oncogene. 2008 Nov 6;27(52):6690-7. doi: 10.1038/onc.2008.283. Epub 2008 Aug 11.
Oncogene. 2008.
PMID: 18695678